Newsletter | November 20, 2026

11.20.26 -- OPCU: Building Analytical Strategies That Support Development And Scale

 

 

Analytical testing supports nearly every decision in drug development, from early characterization through stability studies, release testing, and commercial quality control. As programs advance, sponsors face growing demands for method development, validation, and data that can withstand regulatory review, often while working against tight timelines.

 

Planning analytical work early can help teams avoid delays, maintain consistency during technology transfer, and build a stronger foundation for scale-up and commercial supply. In this edition of the Outsourced Pharma Capabilities Update (OPCU), explore how service providers are approaching analytical development and testing across the product life cycle, with perspectives on method validation, stability programs, and managing outsourced testing partnerships. Watch the presentations below for practical considerations that can help strengthen your analytical strategy.

 

Recent Sessions Available On-Demand                                 
 AI Drug Manufacturing & Viral Vectors – October 2026                             
 mRNA & Packaging, Labeling & Logistics – October 2026                             
 Fill/Finish – October 2026                             
 ADC – October 2026                        

 

Upcoming OPCU Topics & Times               
 Enabling ADC Success | 12/1/2026, PM Session                               
 Mastering Aseptic Fill-Finish | 12/1/2026, PM Session                          

 

Access more on-demand OPCU recordings and upcoming sessions here.

ANALYTICS/LAB SERVICES

Solvias

This presentation explores expertise across a broad range of advanced modalities, including viral vectors, mRNA and lipid nanoparticles, gene-editing tools, and cell-based therapies.

Request Information

Solvias

Alcami

Learn how rigorous microbial challenge programs are designed and executed, with practical lessons for overcoming challenges and demonstrating microbiological safety.

Request Information

Alcami

KBI Biopharma

Anticipate analytical challenges early to prevent commercialization delays. Integrated characterization and quality strategies streamline tech transfer, reduce risk, and support regulatory success.

Request Information

KBI Biopharma